Stock Price Quote

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE5698.5576.75 (+1.37 %)
PREV CLOSE ( ) 5621.80
OPEN PRICE ( ) 5700.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2478
TODAY'S LOW / HIGH ( )5668.70 5768.05
52 WK LOW / HIGH ( )3834.4 6452.85
NSE5705.9084.25 (+1.5 %)
PREV CLOSE( ) 5621.65
OPEN PRICE ( ) 5673.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5705.90 (2)
VOLUME 38139
TODAY'S LOW / HIGH( ) 5656.55 5776.90
52 WK LOW / HIGH ( )3838 6451.15
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-11 1950
Management Info
Pradip Shah - Chairman Meenakshi Nevatia - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerltd.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

08Aug Pfizer informs about newspaper publica
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclos..
27May Pfizer informs about annual secretaria
In terms of Regulation 24(A) of the Securities and Exchange Board of Ind..
22Jan Pfizer informs about appointment of ex
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
18Aug Pfizer informs about change in managem
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
20Jul Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..

Financials

in Millions
QTR Jun 24 ANNUAL 24
Net Profit1507.15513.3
Gross Profit 2026.2 7460.7
Operating Profit 2193.38158.1
Net Sales 5628.621931.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  5987.25 (7.94%)
M.Cap ( in Cr)158942.68
Hester Biosciences (BSE)
peergroup  2379.75 (5.25%)
M.Cap ( in Cr)2024.42
Sanofi India (BSE)
peergroup  6895.70 (1.63%)
M.Cap ( in Cr)15881.23
Glaxosmithkline Phar (BSE)
peergroup  2811.75 (3.79%)
M.Cap ( in Cr)47632.74
Astrazeneca Pharma I (BSE)
peergroup  7864.35 (1.28%)
M.Cap ( in Cr)19660.88

Shareholding Pattern

MUTUAL FUNDS/UTI 8.32%
FI/BANKS/INSURANCE 7.41%
PROMOTERS 63.92%
NON-INSTITUTION 17.02%
GOVERNMENT 0%
FII 0%

About Pfizer Ltd.

Pfizer Ltd. was incorporated in the year 1950. Its today's share price is 5698.55. Its current market capitalisation stands at Rs 26069.57 Cr. In the latest quarter, company has reported Gross Sales of Rs. 23160 Cr and Total Income of Rs.23736.8 Cr. The company's management includes P Rengan, Prajeet Nair, Sonia Singh, Lakshmanan Krishna Kumar, Amit Agarwal, Meena Ganesh, Sunil Lalbhai, Uday Khanna, Meenakshi Nevatia, Pradip Shah.

It is listed on the BSE with a BSE Code of 500680 , NSE with an NSE Symbol of PFIZER and ISIN of INE182A01018. It's Registered office is at The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East)Mumbai-400051, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AF Ferguson & Co, BSR & Co, BSR & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.